Home ETF List About

ETF Holdings Breakdown of MNKD

Stock NameMannKind Corp
TickerMNKD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS56400P7069
LEI213800GFBCNY1ZFST722

MNKD institutional holdings

The adjusted close for MNKD on 2025-11-12 was 5.25

The following institutional investment holdings of MNKD have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 242,595USD 1,273,624 5.25  
2025-11-12 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 101,894USD 534,944 5.25  
2025-11-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 197,557 0.3%USD 1,037,174 0.3% 5.25  
2025-11-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 197,557 0.3%USD 1,037,174 0.3% 5.25  
2025-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 3,115USD 16,354 5.25  
Total =742,718 USD 3,899,270
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with MNKD

Brokerages Set MannKind Corporation (NASDAQ:MNKD) Price Target at $10.71
MannKind Corporation (NASDAQ:MNKD – Get Free Report) has been assigned an average rating of “Buy” from the six brokerages that are presently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among […] - 2025-09-10 02:32:58
MannKind (NASDAQ:MNKD) Shares Gap Up on Analyst Upgrade
MannKind Corporation (NASDAQ:MNKD – Get Free Report) shares gapped up prior to trading on Tuesday after Wells Fargo & Company raised their price target on the stock from $9.00 to $10.00. The stock had previously closed at $4.59, but opened at $6.06. Wells Fargo & Company currently has an overweight rating on the stock. MannKind […] - 2025-09-04 02:20:49
Pre-Market Most Active for Sep 2, 2025 : NIO, TSLL, OPEN, NVDA, SQQQ, BAC, MNKD, TQQQ, TIXT, BABA, SNAP, ACHR
The NASDAQ 100 Pre-Market Indicator is down -332.8 to 23,082.62. The total Pre-Market volume is currently 192,918,332 shares traded.The following are the most active stocks for the pre-market session: NIO Inc. (NIO) is +0.14 at $6.52, with 21,682,127 shares traded. NIO's current - 2025-09-02 09:29:56
MannKind (NASDAQ:MNKD) Shares Up 10.4% Following Analyst Upgrade
MannKind Corporation (NASDAQ:MNKD – Get Free Report) shares rose 10.4% during trading on Wednesday after Royal Bank Of Canada raised their price target on the stock from $7.00 to $8.00. Royal Bank Of Canada currently has an outperform rating on the stock. MannKind traded as high as $4.49 and last traded at $4.50. Approximately 1,795,569 […] - 2025-08-29 02:13:00
MannKind Corporation (NASDAQ:MNKD) Receives Average Rating of “Buy” from Analysts
Shares of MannKind Corporation (NASDAQ:MNKD – Get Free Report) have earned a consensus rating of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month […] - 2025-08-13 02:44:47
Financial Analysis: MannKind (NASDAQ:MNKD) vs. Cocrystal Pharma (NASDAQ:COCP)
Cocrystal Pharma (NASDAQ:COCP – Get Free Report) and MannKind (NASDAQ:MNKD – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Profitability This table compares Cocrystal Pharma and MannKind’s net […] - 2025-08-04 03:01:13
MannKind Corporation (NASDAQ:MNKD) Receives $10.14 Consensus PT from Analysts
Shares of MannKind Corporation (NASDAQ:MNKD – Get Free Report) have been assigned an average recommendation of “Buy” from the eight analysts that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year target price […] - 2025-07-22 02:25:21
MannKind (NASDAQ:MNKD) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of MannKind (NASDAQ:MNKD – Free Report) from a hold rating to a buy rating in a report released on Friday morning. Several other analysts have also recently commented on the stock. HC Wainwright upgraded shares of MannKind to a “buy” rating and set a $9.00 target price for the company […] - 2025-07-21 04:58:50
Cambridge Investment Research Advisors Inc. Buys Shares of 49,255 MannKind Corporation (NASDAQ:MNKD)
Cambridge Investment Research Advisors Inc. bought a new stake in shares of MannKind Corporation (NASDAQ:MNKD – Free Report) during the 1st quarter, Holdings Channel.com reports. The fund bought 49,255 shares of the biopharmaceutical company’s stock, valued at approximately $248,000. A number of other institutional investors have also recently made changes to their positions in the […] - 2025-07-14 04:14:46
MannKind Corporation (NASDAQ:MNKD) Receives $10.33 Average PT from Analysts
Shares of MannKind Corporation (NASDAQ:MNKD – Get Free Report) have been assigned an average recommendation of “Buy” from the seven analysts that are presently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year […] - 2025-06-27 02:37:04
Sowell Financial Services LLC Invests $56,000 in MannKind Corporation (NASDAQ:MNKD)
Sowell Financial Services LLC acquired a new stake in MannKind Corporation (NASDAQ:MNKD – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor acquired 11,089 shares of the biopharmaceutical company’s stock, valued at approximately $56,000. Several other hedge funds have also recently added to or reduced their stakes in MNKD. Principal Financial Group Inc. […] - 2025-06-24 04:46:58
MannKind To Present At Jefferies Global Healthcare Conference; Webcast At 2:35 PM ET
(RTTNews) - MannKind Corp. (MNKD) will present at the Jefferies Global Healthcare Conference, New York. - 2025-06-05 14:35:27
MannKind Co. (NASDAQ:MNKD) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in MannKind Co. (NASDAQ:MNKD – Free Report) by 7.1% during the fourth quarter, HoldingsChannel reports. The firm owned 617,670 shares of the biopharmaceutical company’s stock after purchasing an additional 41,142 shares during the period. UBS AM a distinct business unit […] - 2025-06-05 05:16:58
Mackenzie Financial Corp Buys 47,690 Shares of MannKind Co. (NASDAQ:MNKD)
Mackenzie Financial Corp boosted its stake in MannKind Co. (NASDAQ:MNKD – Free Report) by 146.6% during the 4th quarter, HoldingsChannel reports. The fund owned 80,218 shares of the biopharmaceutical company’s stock after acquiring an additional 47,690 shares during the quarter. Mackenzie Financial Corp’s holdings in MannKind were worth $516,000 as of its most recent SEC […] - 2025-06-04 05:19:00
Analysts Set MannKind Co. (NASDAQ:MNKD) Target Price at $10.00
MannKind Co. (NASDAQ:MNKD – Get Free Report) has earned a consensus rating of “Buy” from the eight brokerages that are presently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among […] - 2025-06-02 03:08:56
State of Wyoming Acquires 4,345 Shares of MannKind Co. (NASDAQ:MNKD)
State of Wyoming raised its holdings in MannKind Co. (NASDAQ:MNKD – Free Report) by 51.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 12,772 shares of the biopharmaceutical company’s stock after purchasing an additional 4,345 shares during the period. State of Wyoming’s holdings in MannKind were worth $82,000 as of its most recent […] - 2025-05-28 05:17:05
MannKind (NASDAQ:MNKD) versus Edesa Biotech (NASDAQ:EDSA) Financial Review
MannKind (NASDAQ:MNKD – Get Free Report) and Edesa Biotech (NASDAQ:EDSA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk. Institutional and Insider Ownership 49.5% of MannKind shares […] - 2025-05-26 03:11:05
MannKind Co. (NASDAQ:MNKD) Shares Sold by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company lessened its stake in MannKind Co. (NASDAQ:MNKD – Free Report) by 3.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 134,613 shares of the biopharmaceutical company’s stock after selling 4,117 shares during the quarter. The Manufacturers Life […] - 2025-05-15 04:45:05
BNP Paribas Financial Markets Boosts Stock Position in MannKind Co. (NASDAQ:MNKD)
BNP Paribas Financial Markets lifted its position in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 66.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 783,474 shares of the biopharmaceutical company’s stock after buying an additional 311,672 shares during […] - 2025-05-14 06:10:54
MannKind Co. (NASDAQ:MNKD) Shares Purchased by Northern Trust Corp
Northern Trust Corp raised its stake in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 8.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,777,784 shares of the biopharmaceutical company’s stock after buying an additional 207,792 shares during the quarter. Northern Trust […] - 2025-05-14 05:18:50
Analysts Set MannKind Co. (NASDAQ:MNKD) PT at $9.56
Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) have been assigned an average rating of “Buy” from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The […] - 2025-05-08 02:52:55
MannKind Co. (NASDAQ:MNKD) Stock Position Lifted by Barclays PLC
Barclays PLC lifted its holdings in MannKind Co. (NASDAQ:MNKD – Free Report) by 6.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 552,143 shares of the biopharmaceutical company’s stock after purchasing an additional 32,278 shares during the quarter. Barclays PLC owned 0.20% of […] - 2025-04-29 05:50:50
Legal & General Group Plc Lowers Position in MannKind Co. (NASDAQ:MNKD)
Legal & General Group Plc trimmed its stake in MannKind Co. (NASDAQ:MNKD – Free Report) by 3.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 337,290 shares of the biopharmaceutical company’s stock after selling 11,167 shares during the period. Legal & […] - 2025-04-25 05:42:57
Invesco Ltd. Lowers Stock Position in MannKind Co. (NASDAQ:MNKD)
Invesco Ltd. lessened its stake in MannKind Co. (NASDAQ:MNKD – Free Report) by 27.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,220,835 shares of the biopharmaceutical company’s stock after selling 464,293 shares during the period. Invesco Ltd. […] - 2025-04-25 04:58:49
Russell Investments Group Ltd. Sells 190,563 Shares of MannKind Co. (NASDAQ:MNKD)
Russell Investments Group Ltd. trimmed its position in MannKind Co. (NASDAQ:MNKD – Free Report) by 31.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 421,659 shares of the biopharmaceutical company’s stock after selling 190,563 shares during the period. Russell […] - 2025-04-18 04:50:56
MannKind Co. (NASDAQ:MNKD) Shares Bought by Geode Capital Management LLC
Geode Capital Management LLC grew its position in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 0.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 6,374,274 shares of the biopharmaceutical company’s stock after purchasing an additional 35,346 shares during the quarter. Geode Capital Management LLC’s holdings in MannKind were worth $40,996,000 as of […] - 2025-04-16 04:40:56
Cibc World Markets Corp Invests $162,000 in MannKind Co. (NASDAQ:MNKD)
Cibc World Markets Corp bought a new stake in MannKind Co. (NASDAQ:MNKD – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 25,204 shares of the biopharmaceutical company’s stock, valued at approximately $162,000. Other hedge funds have […] - 2025-03-27 07:08:51
MannKind Co. (NASDAQ:MNKD) Stake Lifted by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC grew its holdings in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 162.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 50,514 shares of the biopharmaceutical company’s stock after acquiring an additional 31,294 shares during the quarter. Sequoia Financial Advisors LLC’s holdings […] - 2025-03-20 05:48:50
Victory Capital Management Inc. Purchases 171,537 Shares of MannKind Co. (NASDAQ:MNKD)
Victory Capital Management Inc. raised its position in MannKind Co. (NASDAQ:MNKD – Free Report) by 358.6% during the 4th quarter, HoldingsChannel reports. The fund owned 219,367 shares of the biopharmaceutical company’s stock after buying an additional 171,537 shares during the quarter. Victory Capital Management Inc.’s holdings in MannKind were worth $1,411,000 as of its most […] - 2025-03-19 06:18:56
Steward Partners Investment Advisory LLC Lowers Stake in MannKind Co. (NASDAQ:MNKD)
Steward Partners Investment Advisory LLC cut its holdings in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 54.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 12,627 shares of the biopharmaceutical company’s stock after selling 14,804 shares during the period. Steward Partners Investment Advisory LLC’s holdings in MannKind were worth $81,000 as of […] - 2025-03-18 06:11:03

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.